Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing.

CRISPR-Cas9 represents a promising platform for genome editing, yet means for its safe and efficient delivery remain to be fully realized. A novel vehicle that simultaneously delivers the Cas9 protein and single guide RNA (sgRNA) is based on DNA nanoclews, yarn-like DNA nanoparticles that are synthesized by rolling circle amplification. The biologically inspired vehicles were efficiently loaded with Cas9/sgRNA complexes and delivered the complexes to the nuclei of human cells, thus enabling targeted gene disruption while maintaining cell viability. Editing was most efficient when the DNA nanoclew sequence and the sgRNA guide sequence were partially complementary, offering a design rule for enhancing delivery. Overall, this strategy provides a versatile method that could be adapted for delivering other DNA-binding proteins or functional nucleic acids.

[1]  Zhen Gu,et al.  Engineering DNA scaffolds for delivery of anticancer therapeutics. , 2015, Biomaterials science.

[2]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[3]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[4]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[5]  Zhen Gu,et al.  Tailoring nanocarriers for intracellular protein delivery. , 2011, Chemical Society reviews.

[6]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[7]  Suresh Ramakrishna,et al.  Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA , 2014, Genome research.

[8]  Koji Sugiura,et al.  Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease , 2013, Nucleic acids research.

[9]  Daniel K. Bonner,et al.  Self-assembled RNA interference microsponges for efficient siRNA delivery. , 2012, Nature materials.

[10]  R. Barrangou,et al.  Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.

[11]  Hasan Uludağ,et al.  A simple and rapid nonviral approach to efficiently transfect primary tissue–derived cells using polyethylenimine , 2012, Nature Protocols.

[12]  Weihong Tan,et al.  DNA nanoflowers for multiplexed cellular imaging and traceable targeted drug delivery. , 2014, Angewandte Chemie.

[13]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[14]  David V. Schaffer,et al.  Engineering adeno-associated viruses for clinical gene therapy , 2014, Nature Reviews Genetics.

[15]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[16]  J. Keith Joung,et al.  Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo , 2014, Nature Biotechnology.

[17]  David R. Liu,et al.  High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity , 2013, Nature Biotechnology.

[18]  Robert Langer,et al.  CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.

[19]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[20]  Ira Mellman,et al.  Antibody Therapeutics in Cancer , 2013, Science.

[21]  Zhen Gu,et al.  ATP-triggered anticancer drug delivery , 2014, Nature Communications.

[22]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[23]  Robert Langer,et al.  Dendrimeric siRNA for Efficient Gene Silencing. , 2015, Angewandte Chemie.

[24]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[25]  Feng Zhang,et al.  A split-Cas9 architecture for inducible genome editing and transcription modulation , 2015, Nature Biotechnology.

[26]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[27]  Zhen Gu,et al.  Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery , 2014, Journal of the American Chemical Society.

[28]  X. Le,et al.  Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. , 2014, Chemical Society reviews.

[29]  T. Gerngross,et al.  Advances in the production of human therapeutic proteins in yeasts and filamentous fungi , 2004, Nature Biotechnology.

[30]  Jacob K. White,et al.  SPEDRE: a web server for estimating rate parameters for cell signaling dynamics in data-rich environments , 2013, Nucleic Acids Res..

[31]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[32]  Il Young Jung,et al.  DhITACT: DNA Hydrogel Formation by Isothermal Amplification of Complementary Target in Fluidic Channels , 2015, Advanced materials.

[33]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[34]  N. Seeman,et al.  Programmable materials and the nature of the DNA bond , 2015, Science.

[35]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[36]  Chad A. Mirkin,et al.  Importance of the DNA “bond” in programmable nanoparticle crystallization , 2014, Proceedings of the National Academy of Sciences.